KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Revenue (2020 - 2025)

Organon has reported Revenue over the past 6 years, most recently at $1.5 billion for Q4 2025.

  • Quarterly results put Revenue at $1.5 billion for Q4 2025, down 5.34% from a year ago — trailing twelve months through Dec 2025 was $6.2 billion (down 2.92% YoY), and the annual figure for FY2025 was $6.2 billion, down 2.92%.
  • Revenue for Q4 2025 was $1.5 billion at Organon, down from $1.6 billion in the prior quarter.
  • Over the last five years, Revenue for OGN hit a ceiling of $1.6 billion in Q1 2024 and a floor of $1.5 billion in Q4 2022.
  • Median Revenue over the past 5 years was $1.6 billion (2022), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Revenue: decreased 15.39% in 2021 and later grew 7.61% in 2023.
  • Organon's Revenue stood at $1.6 billion in 2021, then dropped by 7.36% to $1.5 billion in 2022, then rose by 7.61% to $1.6 billion in 2023, then dropped by 0.38% to $1.6 billion in 2024, then fell by 5.34% to $1.5 billion in 2025.
  • The last three reported values for Revenue were $1.5 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025) per Business Quant data.